Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

Por Lewis-Wambi, Joan S, Jordan, V Craig
Publicado em 2009

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA

Por Hayes, Erin L, Lewis-Wambi, Joan S
Publicado no Breast Cancer Res (2015)

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer

Por Provance, Olivia K., Lewis-Wambi, Joan
Publicado no Breast Cancer Res (2019)

Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer

Por Jan, Rifat, Huang, Min, Lewis-Wambi, Joan
Publicado em 2012

The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis

Por Maximov, Philipp Y., Lewis-Wambi, Joan S., Jordan, V. Craig
Publicado em 2009

Potential of L-Buthionine Sulfoximine to Enhance the Apoptotic Action of Estradiol to Reverse Acquired Antihormonal Resistance in Metastatic Breast Cancer

Por Lewis-Wambi, Joan S, Swaby, Ramona, Kim, Helen, Jordan, V. Craig
Publicado em 2009

By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy

Por Jordan, V Craig, Patel, Roshani, Lewis-Wambi, Joan S, Swaby, Ramona F
Publicado em 2008

Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells

Por Lui, Asona, New, Jacob, Ogony, Joshua, Thomas, Sufi, Lewis-Wambi, Joan
Publicado no BMC Cancer (2016)

Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator...

Por Ogony, Joshua, Choi, Hye Joung, Lui, Asona, Cristofanilli, Massimo, Lewis-Wambi, Joan
Publicado no Breast Cancer Res (2016)

New Hypotheses and Opportunities in Endocrine Therapy: Amplification of Oestrogen-Induced Apoptosis

Por Jordan, V. Craig, Lewis-Wambi, Joan S., Patel, Roshani R., Kim, Helen, Ariazi, Eric A.
Publicado em 2009

Structure Function Relationships of Estrogenic Triphenylethylenes Related to Endoxifen and 4-Hydroxytamoxifen

Por Maximov, Philipp Y., Myers, Cynthia, Curpan, Ramona F., Lewis-Wambi, Joan S., Jordan, V. Craig
Publicado em 2010

Overexpression of CEACAM6 promotes migration and invasion of oestrogen deprived breast cancer cells

Por Lewis-Wambi, Joan S., Cunliffe, Heather E., Kim, Helen R., Willis, Amanda L., Jordan, V. Craig
Publicado em 2008

The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor α and Cyclin D1

Por Lewis-Wambi, Joan S., Kim, Helen, Curpan, Ramona, Grigg, Ronald, Sarker, Mohammed A., Jordan, V. Craig
Publicado em 2011

Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death

Por Choi, Hye Joung, Lui, Asona, Ogony, Joshua, Jan, Rifat, Sims, Peter J, Lewis-Wambi, Joan
Publicado no Breast Cancer Res (2015)

The Conformation of the Estrogen Receptor Directs Estrogen-Induced Apoptosis in Breast Cancer: A Hypothesis

Por Maximov, Philipp, Sengupta, Surojeet, Lewis-Wambi, Joan S., Kim, Helen R., Curpan, Ramona F., Jordan, V Craig
Publicado em 2011

Oestrogen is bad for patients with breast cancer?

Por Jordan, V Craig, Ariazi, Eric A, Lewis-Wambi, Joan S, Swaby, Ramona R, Cunliffe, Heather E, Riegel, Anna T, Wellstein, Anton
Publicado em 2007

Interaction between MUC1 and STAT1 drives IFITM1 overexpression in aromatase inhibitor-resistant breast cancer cells and mediates estrogen-induced apoptosis

Por Escher, Taylor E., Lui, Asona J., Geanes, Eric S., Walter, Katherine R., Tawfik, Ossama, Hagan, Christy R., Lewis-Wambi, Joan
Publicado no Mol Cancer Res (2019)

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

Por Lewis-Wambi, Joan S, Kim, Helen R, Wambi, Chris, Patel, Roshani, Pyle, Jennifer R, Klein-Szanto, Andres J, Jordan, V Craig
Publicado em 2008

IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21

Por Lui, Asona J., Geanes, Eric S., Ogony, Joshua, Behbod, Fariba, Marquess, Jordan, Valdez, Kelli, Jewell, William, Tawfik, Ossama, Lewis-Wambi, Joan
Publicado no Cancer Lett (2017)

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

Por Lewis-Wambi, Joan S., Kim, Helen R., Wambi, Chris, Patel, Roshani, Pyle, Jennifer R., Klein-Szanto, Andres J., Craig Jordan, V.
Publicado no Breast Cancer Res (2018)